Entity Common Stock, Shares Outstanding of BIOXYTRAN, INC from Q2 2011 to Q3 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Bioxytran, Inc quarterly Entity Common Stock, Shares Outstanding history and change rate from Q2 2011 to Q3 2025.
  • Bioxytran, Inc Entity Common Stock, Shares Outstanding for the quarter ending 14 Nov 2025 was 99.1M shares, a 15.5% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

BIOXYTRAN, INC Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 99.1M +13.3M +15.5% 14 Nov 2025 10-Q 14 Nov 2025
Q2 2025 89M -89M -50% 08 Aug 2025 10-Q 11 Aug 2025
Q1 2025 88.9M -77.6M -46.6% 03 Apr 2025 10-K 03 Apr 2025
Q4 2024 88.1M 13 Jan 2025 10-K/A 13 Jan 2025
Q3 2024 85.8M -58.9M -40.7% 25 Oct 2024 10-Q 29 Oct 2024
Q2 2024 178M +45.4M +34.3% 14 Aug 2024 10-Q 14 Aug 2024
Q1 2024 166M +43M +34.8% 22 Mar 2024 10-K 22 Mar 2024
Q3 2023 145M +21.6M +17.6% 01 Nov 2023 10-Q 03 Nov 2023
Q2 2023 133M +21.7M +19.6% 28 Jul 2023 10-Q 31 Jul 2023
Q1 2023 124M +12.7M +11.4% 30 Mar 2023 10-K 31 Mar 2023
Q3 2022 123M 10 Nov 2022 10-Q 10 Nov 2022
Q2 2022 111M +969K +0.88% 19 May 2022 10-Q 23 May 2022
Q1 2022 111M +10.1M +10% 08 Apr 2022 10-K 11 Apr 2022
Q4 2021 110M 15 Nov 2021 10-Q 17 Nov 2021
Q2 2021 110M +12.8M +13.2% 10 Aug 2021 10-Q 10 Aug 2021
Q1 2021 101M +12.7M +14.5% 06 Apr 2021 10-K 09 Apr 2021
Q3 2020 97.2M +10.7M +12.4% 12 Nov 2020 10-Q 13 Nov 2020
Q2 2020 97M +11.9M +14% 06 Aug 2020 10-Q 07 Aug 2020
Q1 2020 88M +2.92M +3.43% 13 Mar 2020 10-K 18 Mar 2020
Q3 2019 86.5M +1.37M +1.61% 12 Nov 2019 10-Q 13 Nov 2019
Q2 2019 85.2M -25.3M -22.9% 08 Aug 2019 10-Q 09 Aug 2019
Q1 2019 85.1M -22.3M -20.8% 11 Mar 2019 10-K 13 Mar 2019
Q3 2018 85.1M +50.2M +144% 07 Nov 2018 10-Q 08 Nov 2018
Q2 2018 110M +75.5M +216% 24 Jul 2018 10-Q 31 Jul 2018
Q1 2018 107M +83.6M +351% 15 May 2018 10-Q 15 May 2018
Q4 2017 105M +74.2M +238% 31 Dec 2017 10-K 02 Apr 2018
Q3 2017 34.9M +6.75M +24% 07 Nov 2017 10-Q 07 Nov 2017
Q2 2017 34.9M +6.75M +24% 14 Aug 2017 10-Q 14 Aug 2017
Q1 2017 23.8M 31 Mar 2017 10-K 31 Mar 2017
Q4 2016 31.2M +3M +10.7% 08 Dec 2016 10-Q 09 Dec 2016
Q3 2016 28.2M +15.9M +129% 22 Aug 2016 10-Q 20 Sep 2016
Q2 2016 28.2M +22.4M +384% 11 Aug 2016 10-Q 20 Sep 2016
Q4 2015 28.2M +22.3M +384% 31 Dec 2015 10-K 20 Sep 2016
Q3 2015 12.3M -279M -95.8% 12 Nov 2015 10-Q 12 Nov 2015
Q2 2015 5.82M -180M -96.9% 19 May 2015 10-Q 19 May 2015
Q4 2014 5.82M -188M -97% 31 Dec 2014 10-K 10 Apr 2015
Q3 2014 291M +97M +50% 12 Nov 2014 10-Q 13 Nov 2014
Q2 2014 186M -113M -37.9% 12 Aug 2014 10-Q 12 Aug 2014
Q1 2014 186M +2.46M +1.34% 14 May 2014 10-Q 14 May 2014
Q4 2013 194M 31 Dec 2013 10-K 14 Apr 2014
Q3 2013 194M +52.8M +37.4% 14 Nov 2013 10-Q 18 Nov 2013
Q2 2013 299M +170M +132% 09 Aug 2013 10-Q 15 Aug 2013
Q1 2013 183M +64.2M +53.9% 31 Mar 2013 10-Q 15 May 2013
Q3 2012 141M -74.6B 30 Sep 2012 10-Q 21 Nov 2012
Q2 2012 129M +62.6M +94.5% 30 Jun 2012 10-Q/A 22 Jan 2013
Q1 2012 119M 31 Mar 2012 10-Q/A 22 Jan 2013
Q3 2011 74.7B* 30 Sep 2011 10-Q/A 31 Dec 2012
Q2 2011 66.2M 11 Aug 2011 10-Q/A 31 Dec 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.